Get started
L&G HEALTHCARE BREAKTHROUGH UCITS ETFL&G HEALTHCARE BREAKTHROUGH UCITS ETFL&G HEALTHCARE BREAKTHROUGH UCITS ETF

L&G HEALTHCARE BREAKTHROUGH UCITS ETF

No trades
See on Supercharts
Overview
Analysis
Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪65.29 M‬ EUR
Fund flows (1Y)
‪−16.68 M‬ EUR
Dividend yield (indicated)
—
Discount/Premium to NAV
0.4%
Shares outstanding
‪5.15 M‬
Expense ratio
0.49%

About L&G HEALTHCARE BREAKTHROUGH UCITS ETF


Issuer
Legal & General Group Plc
Brand
L&G
Home page
fundcentres.lgim.com
Inception date
Jun 17, 2019
Structure
Irish VCIC
Index tracked
ROBO Global Healthcare Technology and Innovation ETF
Replication method
Physical
Management style
Passive
Primary advisor
LGIM Managers (Europe) Ltd.
ISIN
IE00BK5BC677
The L&G Healthcare Breakthrough UCITS ETF (the ETF) aims to track the performance of the ROBO Global Healthcare Technology and Innovation Index TR (the Index).

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of February 18, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.88%
Health Technology79.90%
Commercial Services6.17%
Technology Services5.72%
Health Services5.07%
Retail Trade1.70%
Electronic Technology1.31%
Bonds, Cash & Other0.12%
Cash0.12%
Stock breakdown by region
79%16%3%
North America79.87%
Europe16.63%
Asia3.51%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows